NO975903L - N-benzylpiperazin-forbindelser, fremgangsmÕte ved fremstilling derav, samt farmas°ytiske blandinger - Google Patents
N-benzylpiperazin-forbindelser, fremgangsmÕte ved fremstilling derav, samt farmas°ytiske blandingerInfo
- Publication number
- NO975903L NO975903L NO975903A NO975903A NO975903L NO 975903 L NO975903 L NO 975903L NO 975903 A NO975903 A NO 975903A NO 975903 A NO975903 A NO 975903A NO 975903 L NO975903 L NO 975903L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- compounds
- preparation
- benzylpiperazine
- pyridyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical class C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- -1 2,3-dithia-cyclopent-1-yl Chemical group 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615415A FR2757164B1 (fr) | 1996-12-16 | 1996-12-16 | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO975903D0 NO975903D0 (no) | 1997-12-16 |
| NO975903L true NO975903L (no) | 1998-06-17 |
Family
ID=9498696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO975903A NO975903L (no) | 1996-12-16 | 1997-12-16 | N-benzylpiperazin-forbindelser, fremgangsmÕte ved fremstilling derav, samt farmas°ytiske blandinger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5849745A (xx) |
| EP (1) | EP0847999B1 (xx) |
| JP (1) | JPH10175967A (xx) |
| CN (1) | CN1192436A (xx) |
| AT (1) | ATE199902T1 (xx) |
| AU (1) | AU720803B2 (xx) |
| BR (1) | BR9706360A (xx) |
| CA (1) | CA2225780C (xx) |
| DE (1) | DE69704329T2 (xx) |
| DK (1) | DK0847999T3 (xx) |
| ES (1) | ES2157541T3 (xx) |
| FR (1) | FR2757164B1 (xx) |
| GR (1) | GR3035855T3 (xx) |
| HU (1) | HUP9702481A3 (xx) |
| NO (1) | NO975903L (xx) |
| NZ (1) | NZ329394A (xx) |
| PL (1) | PL323767A1 (xx) |
| PT (1) | PT847999E (xx) |
| ZA (1) | ZA9711253B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1366015A4 (en) * | 2001-03-01 | 2008-03-26 | Tech Resources Pty Ltd | BENZENE-1 2-DIOL MANNICH BASES, LIGANDS, POLYMERS, AND SELECTIVE METAL ION REMOVAL METHOD |
| FR2827284B1 (fr) * | 2001-07-16 | 2003-10-31 | Servier Lab | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN102993122B (zh) * | 2012-12-24 | 2015-03-04 | 武汉武药制药有限公司 | 盐酸曲美他嗪的合成新路线 |
| ES2919779T3 (es) | 2017-06-20 | 2022-07-28 | Imbria Pharmaceuticals Inc | Derivado de 1-[(2,3,4-trimetoxifenil)metil]-piperazina, composiciones del mismo y métodos para aumentar la eficiencia del metabolismo cardíaco |
| US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3262852A (en) * | 1966-07-26 | Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same | ||
| US2927924A (en) * | 1958-04-03 | 1960-03-08 | Lilly Co Eli | Novel phenethyl-substituted piperazines |
| FR805M (xx) * | 1960-06-30 | 1961-09-01 | ||
| FR1302958A (fr) * | 1961-03-21 | 1962-09-07 | Science Union & Cie | Préparations des dérivés trialcoxylés de la benzyl-1 pipérazine |
| FR1303080A (fr) * | 1961-07-25 | 1962-09-07 | Science Union Et Compagnie Soc | Pipérazines disubstituées |
| CA1326451C (en) * | 1988-01-26 | 1994-01-25 | Nippon Chemiphar Co., Ltd. | Therapeutic agent for liver disease and piperazine derivatives |
| FR2681324B1 (fr) * | 1991-09-18 | 1993-10-29 | Adir Cie | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| FR2703048B1 (fr) * | 1993-03-24 | 1996-01-05 | Adir | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
-
1996
- 1996-12-16 FR FR9615415A patent/FR2757164B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-04 DE DE69704329T patent/DE69704329T2/de not_active Expired - Fee Related
- 1997-12-04 EP EP97402934A patent/EP0847999B1/fr not_active Expired - Lifetime
- 1997-12-04 DK DK97402934T patent/DK0847999T3/da active
- 1997-12-04 PT PT97402934T patent/PT847999E/pt unknown
- 1997-12-04 ES ES97402934T patent/ES2157541T3/es not_active Expired - Lifetime
- 1997-12-04 AT AT97402934T patent/ATE199902T1/de not_active IP Right Cessation
- 1997-12-15 JP JP9344823A patent/JPH10175967A/ja active Pending
- 1997-12-15 US US08/990,611 patent/US5849745A/en not_active Expired - Fee Related
- 1997-12-15 NZ NZ329394A patent/NZ329394A/xx unknown
- 1997-12-15 PL PL97323767A patent/PL323767A1/xx unknown
- 1997-12-15 ZA ZA9711253A patent/ZA9711253B/xx unknown
- 1997-12-16 CN CN97107273A patent/CN1192436A/zh active Pending
- 1997-12-16 CA CA002225780A patent/CA2225780C/fr not_active Expired - Fee Related
- 1997-12-16 AU AU48422/97A patent/AU720803B2/en not_active Ceased
- 1997-12-16 BR BR9706360A patent/BR9706360A/pt not_active Application Discontinuation
- 1997-12-16 HU HU9702481A patent/HUP9702481A3/hu unknown
- 1997-12-16 NO NO975903A patent/NO975903L/no not_active Application Discontinuation
-
2001
- 2001-05-11 GR GR20010400707T patent/GR3035855T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ329394A (en) | 1998-10-28 |
| BR9706360A (pt) | 1999-06-01 |
| PL323767A1 (en) | 1998-06-22 |
| CA2225780A1 (fr) | 1998-06-16 |
| ATE199902T1 (de) | 2001-04-15 |
| EP0847999B1 (fr) | 2001-03-21 |
| FR2757164A1 (fr) | 1998-06-19 |
| CA2225780C (fr) | 2002-11-19 |
| JPH10175967A (ja) | 1998-06-30 |
| EP0847999A1 (fr) | 1998-06-17 |
| AU720803B2 (en) | 2000-06-15 |
| PT847999E (pt) | 2001-08-30 |
| AU4842297A (en) | 1998-06-18 |
| HUP9702481A3 (en) | 1999-03-01 |
| DE69704329D1 (de) | 2001-04-26 |
| HU9702481D0 (en) | 1998-03-02 |
| US5849745A (en) | 1998-12-15 |
| GR3035855T3 (en) | 2001-08-31 |
| NO975903D0 (no) | 1997-12-16 |
| ES2157541T3 (es) | 2001-08-16 |
| DK0847999T3 (da) | 2001-04-30 |
| HUP9702481A2 (hu) | 1998-07-28 |
| DE69704329T2 (de) | 2001-09-20 |
| FR2757164B1 (fr) | 1999-01-22 |
| CN1192436A (zh) | 1998-09-09 |
| ZA9711253B (en) | 1998-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO932005L (no) | Angiotensin-II-antagonister | |
| MX9306831A (es) | Nuevos compuestos heterociclicos. | |
| AP9901442A0 (en) | 4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists. | |
| DK1178967T3 (da) | Quinolinderivater som inhibitorer af MEK-enzymer | |
| AU579472B2 (en) | Amides derived from quinoline, processes for preparation thereof and pharmaceutical compositions containing them | |
| DE59702414D1 (de) | Dipeptidische benzamidine als kininogenasen-inhibitoren | |
| ES2190469T3 (es) | Derivados de isocumarina y su uso en farmacos. | |
| DK0976748T3 (da) | Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet | |
| NO862621L (no) | Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater. | |
| MY132009A (en) | Pharmaceutical compounds. | |
| DK0684241T3 (da) | N-pyridylcarboxamidderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse | |
| NO983493L (no) | Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike | |
| NO20022232L (no) | Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII | |
| AU591165B2 (en) | Angiotensin converting enzyme inhibitors | |
| KR860005794A (ko) | 이미다졸 유도체의 제조방법 | |
| NO975903L (no) | N-benzylpiperazin-forbindelser, fremgangsmÕte ved fremstilling derav, samt farmas°ytiske blandinger | |
| DK163581C (da) | Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne | |
| EP0436734A4 (en) | New aminopiperazine derivatives | |
| NO892170D0 (no) | Buten- eller propensyrederivater og fremgangsmaate for deres fremstilling. | |
| DE68903680D1 (de) | 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion-2,4-derivate, deren herstellung und verwendung als heilmittel. | |
| HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| NO921159L (no) | Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer | |
| NO972731D0 (no) | Thiazolidinonforbindelser eller middel inneholdende disse for å behandle eller forhindre angina pectoris | |
| NO972943D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
| MX9303976A (es) | Derivados de 2-amino-n-{{((4-(aminocarbonil)-pirimidin-2-il-amino)-alquil}-pirimidi n-4-carboxamida, su preparacion y su aplicacion en terapeutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |